Cargando…
Pulmonary Sarcoidosis following Etanercept Treatment
Tumour necrosis factor (TNF) is an important cytokine involved in the pathology of a number of inflammatory conditions, and thus blockade with anti-TNF therapies is becoming the cornerstone in managing such diseases. With increasing use, evidence is collected for the association of sarcoid-like gran...
Autores principales: | Bhamra, Kuljeet, Stevens, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540653/ https://www.ncbi.nlm.nih.gov/pubmed/23320239 http://dx.doi.org/10.1155/2012/724013 |
Ejemplares similares
-
Pulmonary Sarcoidosis following Etanercept Treatment for Ankylosing Spondylitis: A Case Report and Review of the Literature
por: Majjad, A., et al.
Publicado: (2018) -
Systemic sarcoidosis induced by etanercept: first Brazilian case
report
por: Unterstell, Natasha, et al.
Publicado: (2013) -
Mononeuritis multiplex as the first presentation of refractory sarcoidosis responsive to etanercept
por: Marques, Inês Brás, et al.
Publicado: (2014) -
Development of Propionibacterium acnes-associated Sarcoidosis During Etanercept Therapy
por: Isshiki, Takuma, et al.
Publicado: (2019) -
Epididymo-Orchitis as a Presenting Feature of Relapsing Polychondritis: A Case Report
por: Bhamra, Kuljeet, et al.
Publicado: (2011)